Healthcare - Biotechnology - NASDAQ - US
$ 3.1
-15.5 %
$ 28.6 M
Market Cap
-0.49
P/E
BALANCE SHEET
83.9 M
ASSETS
26.6 M
LIABILITIES
57.3 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
SAB Biotherapeutics, Inc.
| Current Assets | 58.9 M |
| Cash & Short-Term Investments | 56.6 M |
| Receivables | 0 |
| Other Current Assets | 2.34 M |
| Non-Current Assets | 25 M |
| Long-Term Investments | 0 |
| PP&E | 24.7 M |
| Other Non-Current Assets | 350 K |
| Current Liabilities | 10.8 M |
| Accounts Payable | 946 K |
| Short-Term Debt | 2.65 M |
| Other Current Liabilities | 7.21 M |
| Non-Current Liabilities | 15.8 M |
| Long-Term Debt | 4.05 M |
| Other Non-Current Liabilities | 11.8 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 56.6 | 15.0 | 33.2 | 12.6 | 6.3 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 5.6 | 8.0 | 20.6 | 2.8 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 2.3 | 1.5 | 9.0 | 1.3 | 0.1 |
| Total Current Assets | 58.9 | 22.1 | 48.4 | 34.5 | 9.3 |
| PP&E | 24.7 | 28.3 | 30.9 | 22.1 | 8.7 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0.4 | 0.5 | 0 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 83.9 | 50.9 | 79.4 | 56.5 | 18.0 |
| LIABILITIES | |||||
| Accounts Payable | 0.9 | 3.7 | 4.5 | 7.4 | 2.2 |
| Short Term Debt | 2.7 | 2.0 | 3.1 | 1.7 | 1.9 |
| Other Current Liabilities | 5.9 | 9.2 | 16.8 | 1.9 | (4.1) |
| Total Current Liabilities | 10.8 | 15.0 | 24.7 | 11.1 | 4.6 |
| Long Term Debt | 4.1 | 4.5 | 5.4 | 6.5 | 53.4 K |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 11.8 | 0.3 | 10.7 | 0 | 15.6 |
| Total Liabilities | 26.6 | 19.8 | 40.8 | 17.5 | 20.3 |
| EQUITY | |||||
| Common Stock | 929 | 5.09 K | 4.35 K | 3.52 K | 3.52 K |
| Retained Earnings | (90.1) | (47.9) | (29.1) | (12.0) | (32.1) |
| Other Accumulative Comprehensive Income/Loss | 26.4 K | 0 | 0 | 0 | 0 |
| Total Equity | 57.3 | 31.1 | 38.5 | 39.0 | (2.3) |
| Total Liabilities and Equity | 83.9 | 50.9 | 79.4 | 56.5 | 18.0 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 5.5 | 4.4 | 2.7 | 2.5 | 43.5 |